EBSCO Health
EBSCO Health, the healthcare division of privately-held EBSCO Information Services, provides evidence-based clinical decision support platforms (DynaMed, DynaMedex, Dynamic Health), research databases, and AI-powered tools to physicians, nurses, allied health professionals, and healthcare institutions globally via enterprise subscriptions.
- Company typePrivate
- Founded1944
- HeadquartersIpswich, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What EBSCO Health does
EBSCO Health is the healthcare division of EBSCO Information Services, a privately held, family-owned company founded in 1944 and headquartered in Ipswich, Massachusetts. The division provides evidence-based clinical decision support solutions, shared decision-making resources, healthcare business intelligence, and peer-reviewed medical research information to physicians, nurses, allied health professionals, and healthcare research institutions globally. Its core product portfolio centers on DynaMed, DynaMedex, and Dynamic Health — clinical decision support platforms that deliver fast, accurate, and actionable answers at the point of care — supplemented by research databases (CINAHL Ultimate, MEDLINE Ultimate) and acquired clinical tools (GIDEON, Isabel, ViDAL Consult, Patient Education Reference Center).
The company's technology stack rests on a curated, peer-reviewed clinical knowledge base that has been built and maintained for decades, with DynaMed holding exclusive licensed rights to publish same-day summaries of New England Journal of Medicine articles. In February 2026, EBSCO Health launched Dyna AI Mode and Dyna AI, purpose-built generative AI interfaces that sit on top of the DynaMed, DynaMedex, and Dynamic Health platforms to provide evidence-grounded answers with source transparency. The company cites clinician survey data showing 80% trust in evidence-based AI-CDS tools, 89% believing AI-CDS will improve patient outcomes, and 75% of AI-CDS users reporting time savings of four or more minutes per patient encounter. AI capabilities are currently restricted in the European Union.
EBSCO Health operates a recurring institutional subscription revenue model sold through enterprise field sales to hospitals, health systems, and academic medical centers across 14+ countries. Pricing is quote-based and not publicly disclosed, with annual billing cadence. Distribution occurs via the EBSCOhost research platform and EBSCO Mobile App. The division is supported by strategic content partnerships (NEJM, AWHONN) and a technology integration partnership with clinical AI platform Avo. EBSCO Health is part of a parent organization employing 1,001-5,000 people and has never undergone an IPO or external acquisition, remaining under founding family ownership.
EBSCO Health firmographics
Firmographics- Name
- EBSCO Health
- Legal name
- EBSCO Information Services
- Website
- https://health.ebsco.com
- Company type
- Private
- Founded year
- 1944
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- EBSCO Health, the healthcare division of privately-held EBSCO Information Services, provides evidence-based clinical decision support platforms (DynaMed, DynaMedex, Dynamic Health), research databases, and AI-powered tools to physicians, nurses, allied health professionals, and healthcare institutions globally via enterprise subscriptions.
- Ownership category
- akta.pro rank
EBSCO Health industry classification
Industry- Product category
- Clinical Decision Support Systems
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Physicians (6211)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Patient Intake, Digital Registration & eForms (HLACAEAF)
Keywords
Where EBSCO Health is headquartered
LocationHeadquarters
- HQ city
- Ipswich
- HQ country
- United States
- HQ region
- North America
Markets served
EBSCO Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- Clinical Decision Support Subscriptions: EBSCO Health generates revenue through institutional subscriptions to clinical decision support platforms including DynaMed, DynaMedex, Dynamic Health, and research databases like CINAHL Ultimate and MEDLINE Ultimate
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Institutional subscription plans for healthcare organizations |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
EBSCO Health product offering
Product offeringCore offering
EBSCO Health provides evidence-based clinical decision support software platforms — including DynaMed, DynaMedex, and Dynamic Health — that deliver fast, actionable answers to clinicians at the point of care. Its portfolio also includes nursing/allied health research databases (CINAHL Ultimate, MEDLINE Ultimate), specialized clinical tools (GIDEON, Isabel, ViDAL Consult), patient education resources, and the AI-powered Dyna AI / Dyna AI Mode interface. Products are sold primarily as institutional subscriptions to hospitals, health systems, and academic medical centers worldwide.
Product overview
EBSCO Health is a portfolio of clinical decision support solutions organized around a core platform-plus-modules architecture. The primary offerings include DynaMed, DynaMedex, and Dynamic Health as the main clinical decision support platforms, supplemented by specialized tools like DynaMed Decisions, CINAHL Ultimate, and MEDLINE Ultimate for research. The portfolio also includes acquired and partner brands such as GIDEON, Isabel, Isabel Symptom Checker, Patient Education Reference Center, and ViDAL Consult. The recent Dyna AI and Dyna AI Mode additions represent AI-powered interfaces integrated across the core platforms. The portfolio serves physicians, nurses, allied health professionals, and patients through evidence-based content, shared decision-making resources, and healthcare business intelligence.
Differentiator
Problem solved
Functional benefit
Brands
- DynaMed: Clinical decision support solution providing fast, accurate and actionable answers at the point of care
- DynaMedex
- Dynamic Health
- Dyna AI Mode
- Dyna AI
- CINAHL Ultimate
- MEDLINE Ultimate
Products and services
- DynaMed Clinical decision support solution that provides fast, accurate, and actionable answers to clinical questions at the point of care for physicians and healthcare providers, with the only licensed same-day access to New England Journal of Medicine content.
- DynaMed Decisions Clinical decision support solution within the DynaMed suite focused on decision-making support for healthcare providers, supporting shared decision-making with patients.
- DynaMedex
- Dynamic Health
- Dyna AI
- CINAHL Ultimate
- MEDLINE Ultimate
- GIDEON
- Isabel
- Isabel Symptom Checker
- Patient Education Reference Center
- ViDAL Consult
Quantifiable outcome
- 80% of clinicians trust evidence-based AI tools
- +3 more outcomes
Companies that use EBSCO Health
Customer profileSegments3 records
Ideal customer profiles1 record
EBSCO Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
EBSCO Health partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN)coreEBSCO Clinical Decisions announced a strategic partnership with AWHONN at the 2026 AWHONN Convention to integrate AWHONN's clinical expertise into EBSCO's Dynamic Health platform. AWHONN subject matter experts will conduct clinical reviews of nursing skills content, ensuring resources remain aligned with current best practices and undergo annual re-evaluation. The partnership aims to provide frontline nurses with validated, evidence-based knowledge accessible through clinical workflows to standardize care delivery and improve patient outcomes.
- New England Journal of Medicine (NEJM)coreDynaMed entered into an agreement with the New England Journal of Medicine to publish summaries of select NEJM research articles in real time within its platform. DynaMed is the only clinical decision support solution with licensed rights to same-day access to NEJM articles, addressing the demand for rapid access to clinical information at the point of care. The summaries will be available via web on the homepage and within clinical topics on the same day the NEJM embargo is lifted.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
EBSCO Health competitors and assessment
Company assessmentDirect peers
- Elsevier (ClinicalKey, ClinicalPath): Elsevier's ClinicalKey competes head-to-head with DynaMedex (which already combines DynaMed with Elsevier data) and offers clinical decision support plus drug/disease reference content to hospitals and academic medical centers.
- BMJ (BMJ Best Practice): BMJ Best Practice is a clinical decision support tool for physicians at the point of care, offering evidence-based summaries similar to DynaMed and used internationally across hospital systems.
- Wolters Kluwer (UpToDate, Lexicomp): UpToDate is the market-leading clinical decision support platform for physicians, directly competing with DynaMed across hospitals and health systems globally. Wolters Kluwer's clinical solutions also include Lexicomp for drug information, paralleling DynaMedex.
- Merative (Micromedex): Micromedex is a long-standing drug and disease reference solution used by hospitals and health systems, directly competing with the drug information capabilities of DynaMedex and ViDAL Consult.
Emerging players
- PEPID: PEPID offers evidence-based clinical decision support for clinicians across hospital and point-of-care settings, including drug and disease information, overlapping with EBSCO's clinical reference portfolio.
- VisualDx: VisualDx is an AI-driven clinical decision support system focused on differential diagnosis and image-based clinical decision making, used by hospitals and serving as an emerging alternative to EBSCO's Isabel diagnostic tool.
- Epocrates (athenahealth): Epocrates is a clinical reference app widely used by physicians for drug information and clinical content, overlapping with DynaMedex and ViDAL Consult for point-of-care drug and disease reference.
- OpenEvidence: OpenEvidence is an AI-powered clinical decision support tool for clinicians that synthesizes medical literature, representing an emerging AI-native competitor to Dyna AI Mode in the point-of-care evidence retrieval category.
- FDB (First Databank): First Databank provides drug knowledge and medication decision support solutions integrated into EHR workflows, directly competing with the clinical drug information capabilities within DynaMedex and ViDAL Consult.
- Atropos Health: Atropos Health offers AI-powered real-world evidence and clinical decision support tools that complement traditional CDS platforms, representing an emerging adjacency to EBSCO's evidence-based decision support portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
EBSCO Health social profiles
Digital presenceEBSCO Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
EBSCO Health leadership team
Management profileNumber of profiles
Profiles2 records
EBSCO Health subsidiaries and ownership
Company hierarchySubsidiaries11 records
EBSCO Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EBSCO Health M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EBSCO Health
What does EBSCO Health do?
EBSCO Health provides evidence-based clinical decision support software platforms — including DynaMed, DynaMedex, and Dynamic Health — that deliver fast, actionable answers to clinicians at the point of care. Its portfolio also includes nursing/allied health research databases (CINAHL Ultimate, MEDLINE Ultimate), specialized clinical tools (GIDEON, Isabel, ViDAL Consult), patient education resources, and the AI-powered Dyna AI / Dyna AI Mode interface. Products are sold primarily as institutional subscriptions to hospitals, health systems, and academic medical centers worldwide.
Is EBSCO Health a public or private company?
EBSCO Health is a private company. It is classified as family owned and is currently operating.
When was EBSCO Health founded?
EBSCO Health was founded in 1944. It employs 1,001 to 5,000 people.
Where is EBSCO Health based?
EBSCO Health is headquartered in Ipswich, United States, in the North America region.
How does EBSCO Health make money?
One revenue line is on record: clinical Decision Support Subscriptions.
Who are EBSCO Health's main competitors?
Direct peers on record are Elsevier (ClinicalKey, ClinicalPath), BMJ (BMJ Best Practice), Wolters Kluwer (UpToDate, Lexicomp) and Merative (Micromedex). Emerging players are PEPID, VisualDx, Epocrates (athenahealth), OpenEvidence, FDB (First Databank) and Atropos Health.
Does EBSCO Health have an API?
No public API is recorded for EBSCO Health.
What industry is EBSCO Health in?
EBSCO Health's product category is Clinical Decision Support Systems. Its primary akta.pro industry code is HLACAEAF, Patient Intake, Digital Registration & eForms. Its NAICS code is 524292 and its SIC code is 7372.